(Report ID: 114056) Drug interactions analysis of: Betaseron, Norvasc, Atenolol, Diovan, Baclofen, Folic Acid, MethotrexateMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 19, 2008, eHealthMe analyzes 10,180,564 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 19, 2008: 4 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 114056 | May, 4, 2006 | 59 | Female |
List of drugs the patient takes:
| Drug |
Betaseron |
Norvasc |
Atenolol |
Diovan |
Baclofen |
Folic Acid |
Methotrexate |
List of drug interactions, adverse side effects / events the patient has:
| Name |
Amnesia |
Asthenia |
Blindness Unilateral |
Cerebrovascular Accident |
Condition Aggravated |
Difficulty In Walking |
Headache |
Loss Of Consciousness |
Multiple Sclerosis |
Thermal Burn |
Tremor |
Urinary Incontinence |
Visual Acuity Reduced |
Results from eHealthMe: 4 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Amnesia | 2 (50.00%) |
Asthenia | 1 (25.00%) |
Blindness Unilateral | 3 (75.00%) |
Cerebrovascular Accident | 2 (50.00%) |
Condition Aggravated | 3 (75.00%) |
Difficulty In Walking | 2 (50.00%) |
Headache | 3 (75.00%) |
Loss Of Consciousness | 4 (100.00%) |
Multiple Sclerosis | 4 (100.00%) |
Thermal Burn | 4 (100.00%) |
Tremor | 4 (100.00%) |
Urinary Incontinence | 3 (75.00%) |
Visual Acuity Reduced | 2 (50.00%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:
3) Top co-used drugs drugs reported for the past 12 months:
4) Top drug interactions, adverse side effects reported of all time:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Tremor | 4 (100.00%) |
2 | Thermal Burn | 4 (100.00%) |
3 | Multiple Sclerosis | 4 (100.00%) |
4 | Loss Of Consciousness | 4 (100.00%) |
5 | Headache | 3 (75.00%) |
6 | Urinary Incontinence | 3 (75.00%) |
7 | Blindness Unilateral | 3 (75.00%) |
8 | Condition Aggravated | 3 (75.00%) |
9 | Visual Acuity Reduced | 2 (50.00%) |
10 | Cerebrovascular Accident | 2 (50.00%) |
5) Top co-used drugs drugs reported of all time:
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Simvastatin (Accord Hlthcare) - 20MG for Hyperlipidemia (Nov, 19, 2008)
|
Gemzar (Lilly) - EQ 1GM BASE/VIAL for Cancer (Nov, 19, 2008)
|
Gemzar (Lilly) - EQ 1GM BASE/VIAL for Cancer (Nov, 19, 2008)
|
Side effects comparison of Zetia (Msp Singapore) - 10MG (Nov, 19, 2008)
|
Ramipril 10 MG for Blood Pressure (Nov, 19, 2008)
|
Wellbutrin Sr (Glaxosmithkline) - 150MG for Depression (Nov, 19, 2008)
|
Bupropion Hydrochloride (Sandoz) - 10... for Depression (Nov, 19, 2008)
|
Albuterol (Armstrong Pharms) - 0.09MG... for Asthma (Nov, 19, 2008)
|
Albuterol for Asthma (Nov, 19, 2008)
|
Digoxin for Atrial Fibrillation/flutter (Nov, 19, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|